Gonadotropin-releasing Hormone Agonist

1

Review clinical trials related to Gonadotropin-releasing Hormone Agonist. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE)

While most of the children spontaneously recover menstruation or experienced normal puberty after chemotherapy, their ovarian reserve may be impaired by treatment inducing future infertility. Fertility preservation is currently proposed for selected prepubertal patients with a high risk of premature ovarian failure after treatment (mostly conditioning regimen for bone marrow transplantation). For patients with low or moderate risks, counselling is very difficult and no fertility preservation procedure is usually proposed for these patients as no marker of the ovarian reserve has been validated in this young population to assess the individual risk. The primary objective of the study is to prevent long-term treatment-related infertility by detecting the young patients who normally progressed to menarche but have a reduced ovarian reserve. These patients may benefit from particular follow-up and fertility preservation procedure.

Participants needed: 275
Trial details
Age: 3-14Biological sex: FemaleType: ObservationalSponsor: Erasme University HospitalUpdated: May 4, 2020Locations: 10
Eligibility criteria

High risk : Conditioning therapy for bone marrow transplantation or pelvic irrad... [+2]

CNS (central nervous system) irradiation, cerebral tumour [+4]